Cutaneous Leishmaniasis Completed Phase 4 Trials for Miltefosine (DB09031)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01462500Pharmacokinetics of Miltefosine in Children and AdultsTreatment